Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results

Go back to Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) Delayed: 5.33 -0.05 (0.93%)
Previous Close $5.38    52 Week High $18.00 
Open $5.42    52 Week Low $6.91 
Day High $5.42    P/E N/A 
Day Low $5.31    EPS $-0.67 
Volume 81,209